Goldman Sachs asks U.S. employees about vaccination status - memo
Reuters
Published Jun 10, 2021 09:27AM ET
(Reuters) - Goldman Sachs Group Inc (NYSE:GS) has asked its U.S. employees to report their COVID-19 vaccination status by Thursday afternoon as the Wall Street bank plans their return to the office, according to a memo seen by Reuters.
The New York-based investment bank, which has nearly 40,000 employees around the world, is planning to bring U.S. employees back to the office by mid-June.
It said in the memo it was mandatory for employees to submit their vaccination status.
"While we strongly encourage you to receive a COVID-19 vaccine, we understand that the choice to get vaccinated is a personal one," the bank said.
The return-to-office push gained momentum in March when Chief Executive Officer David Solomon said the bank owes it to its incoming class of analysts and interns to have them come to work in offices.
Banks globally are adopting different methods to ensure a successful back to office plan, including hybrid working models and vaccination drives.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.